Cents and Sensibility - Kimberly and Friends' Consortium Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Cents and Sensibility - Kimberly and Friends' Consortium

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Walk Softly who wrote (51220)	12/27/1999 11:22:00 AM
From: Walk Softly	Read Replies (1) of 108040

TKTX gene therapy researcher ready to blow... ....development-stage biopharmaceutical company specializes in researching gene therapies that activate malfunctioning genes, causing them to produce proteins that are necessary for proper operation...... example: blood clotting factors that result in hemophilia A...... does not rely on using cloned genes, instead it is developing a way to graft activating DNA sequences directly to the genes, which will then reproduce correctly...... deals with Hoechst Marion Roussel and the National Institutes of Health......

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next